Dr. Kevin Spelman is a molecular biologist, phytochemist and phytotherapist who has worked with medicinal plants in the field, in the clinic, and in research models including clinical human trials and preclinical models. He has practiced phytotherapy at several clinics and was a cofounder of the first full accredited Master of Science degree in Clinical Herbal Medicine. As a postdoctoral fellow at the National Institute on Aging he researched the molecular biology of brain and ovarian cancer and predicted and demonstrated novel phytocannabinoid ligands from Zanthoxylum spp. Dr. Spelman was a Marie Curie Research Fellow in the EU researching medicinal plants against malaria.

His doctoral work connected metabolic and immunological function and elucidated an endocannabinoid novel target for Echinacea spp. Dr. Spelman has been an editor, reviewer and contributed to the knowledge base in Integrative Medicine with over 2 dozen publications in peer reviewed journals and industry magazines. Dr. Spelman also publishes an audio science journal The Spelman Report: PhytoPharmacology Review highlighting clinically relevant research on natural products. He also runs Health, Education & Research a consulting company for the natural products and cannabis industry which offers formulation and other services to the industry.